- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VRTX
Recent news which mentions VRTX
CRISPR Therapeutics (CRSP) Stock Jumps as U.K. Authorizes Gene Therapy
November 16, 2023
From InvestorPlace
UK Approves First Crispr Gene Edited Therapy For Sickle Cell Disease, Beta Thalassemia
November 16, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 15, 2023
From Benzinga
How Is The Market Feeling About Vertex Pharmaceuticals?
November 14, 2023
Tickers
VRTX
From Benzinga
Right Now Could Be a Once-in-a-Generation Opportunity to Buy These Cathie Wood Stocks
November 14, 2023
From Motley Fool
2 Stocks to Buy Hand Over Fist as the S&P 500 Rockets Higher
November 14, 2023
From Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
November 12, 2023
From Motley Fool
1 No-Brainer Stock to Buy and Hold for 10 Years
November 11, 2023
From Motley Fool
3 Growth Stocks to Buy Right Now Without Any Hesitation
November 11, 2023
From Motley Fool
4 First-in-Their-Class Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
November 11, 2023
From Motley Fool
3 Biotech Stocks That Are Betting on the Future of Gene Editing
November 09, 2023
From InvestorPlace
This Program for a Common Problem May Be Vertex Pharmaceuticals' Ticket to a New Wave of Billion-Dollar Revenues
November 09, 2023
From Motley Fool
4 Reasons to Worry About Vertex Pharmaceuticals -- Debunked
November 08, 2023
Tickers
VRTX
From Motley Fool
What 10 Analyst Ratings Have To Say About Vertex Pharmaceuticals
November 07, 2023
Tickers
VRTX
From Benzinga
S&P 500, Nasdaq Set To Break 6-Day Rally Today? Traders Await Fed Cues, Analyst Says Seasonal Rally Has Started With Gusto
November 07, 2023
From Benzinga
Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call Transcript
November 07, 2023
Tickers
VRTX
From Motley Fool
Earnings Scheduled For November 6, 2023
November 06, 2023
From Benzinga
US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields
November 06, 2023
From Benzinga
S&P 500 futures show stocks extending latest rally
November 06, 2023
From MarketWatch
7 Tech Stocks to Buy and Hold for the Next 25 Years
November 05, 2023
From InvestorPlace
Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets
November 03, 2023
From Benzinga
Here's What Investors Need to Know About Vertex Pharmaceuticals and CRISPR Therapeutics' Big Day at the FDA
November 03, 2023
From Motley Fool
One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?
November 02, 2023
From Motley Fool
Crispr Therapeutics’ stock soars as FDA-panel meeting raises hopes sickle-cell-disease drug will be approved
November 01, 2023
From MarketWatch
Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
November 01, 2023
Tickers
VRTX
From Benzinga
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
October 30, 2023
From Motley Fool
From Motley Fool
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.